Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 5/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7125661 | 0.86 | L3MBTL1 (0.38) | NPC1MEN1KMT2AALDH1A1RAB9A | |
| SCHEMBL7117619 | 0.84 | PLK1 (0.38) | EGLN1GAATDP1POLB | |
| SCHEMBL7709554 | 0.76 | MAPT (0.34) | NPC1MEN1KMT2AALDH1A1RAB9A | |
| SCHEMBL13897459 | 0.74 | KMT2A (0.50) | NPC1MEN1KMT2AALDH1A1RAB9A | |
| SCHEMBL30887148 | 0.73 | HPGD (0.42) | NPC1GAAMAPTTDP1LMNA | |
| SCHEMBL6551878 | 0.73 | PDIA6 (0.37) | NPC1GAATDP1 | |
| SCHEMBL25373978 | 0.73 | PPARG (0.36) | NPC1MEN1KMT2AALDH1A1RAB9A | |
| SCHEMBL28965238 | 0.72 | LMNA (0.47) | NPC1MEN1KMT2AALDH1A1GAA | |
| SCHEMBL7703825 | 0.72 | — | — | |
| SCHEMBL30887231 | 0.72 | HTT (0.43) | NPC1MEN1KMT2AALDH1A1FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6355708-B2 | USEFUL IN STABILIZING POLYMERS AND OTHER MATERIALS FROM DEGRADATION BY ENVIRONMENTAL FORCES SUCH AS ACTINIC RADIATION (ULTRAVIOLET LIGHT), OXIDATION, MOISTURE, ATMOSPHERIC POLLUTANTS | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-03-12 | — | — | US | disclosed |
| US-20010031866-A1 | Novel trisaryl-1,3,5-triazine ultraviolet light absorbers | GUPTA RAM BABOO (US) | 2001-10-18 | — | — | US | disclosed |
| US-6242597-B1 | STABILIZERS WITH A BONDABLE GROUP HAVING AN ACTIVE (ACIDIC) HYDROGEN; MIGRATION BETWEEN POLYMER LAYERS IS REDUCED | CIBA SPECIALTY CHEMICALS CORPORATION | 2001-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010031866-A1 | Novel trisaryl-1,3,5-triazine ultraviolet light absorbers | ERCC5, XRCC5, ERCC1 | NPC1 2328/4885MEN1 2954/4885KMT2A 2545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.